8-132824010-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016018.5(PHF20L1):c.1586C>T(p.Ser529Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000017 in 1,588,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016018.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF20L1 | NM_016018.5 | c.1586C>T | p.Ser529Leu | missense_variant | 13/21 | ENST00000395386.7 | NP_057102.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHF20L1 | ENST00000395386.7 | c.1586C>T | p.Ser529Leu | missense_variant | 13/21 | 5 | NM_016018.5 | ENSP00000378784.2 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151446Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000206 AC: 5AN: 242974Hom.: 0 AF XY: 0.0000304 AC XY: 4AN XY: 131658
GnomAD4 exome AF: 0.0000181 AC: 26AN: 1437444Hom.: 0 Cov.: 26 AF XY: 0.0000223 AC XY: 16AN XY: 716234
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151446Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73930
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2023 | The c.1586C>T (p.S529L) alteration is located in exon 13 (coding exon 12) of the PHF20L1 gene. This alteration results from a C to T substitution at nucleotide position 1586, causing the serine (S) at amino acid position 529 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at